Boyd, A.E., Modi, S., Howard, S.J., Moore, C.B., Keevil, B.G. and Denning, D.W. (2004) Adverse Reactions to Voriconazole. Clinical Infectious Diseases, 39, 1241-1244.
https://doi.org/10.1086/424662

has been cited by the following article:

• TITLE: Determination of Voriconazole in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry: Application in Therapeutic Drug Monitoring

  AUTHORS: Waleed Alhussaini, Ezzeldeen Ghanem, Magd Alsahly, Amani Kurdi, Eman Alharbi, Imadul Islam, Majed Aljeraisy

  KEYWORDS: Voriconazole, Human Plasma, Liquid Chromatography, Tandem Mass Spectrometry, Therapeutic Drug Monitoring

  JOURNAL NAME: American Journal of Analytical Chemistry, Vol.14 No.9, September 26, 2023

  ABSTRACT: A sensitive, accurate and robust Liquid Chromatography Tandem Mass Spectrometry method has been developed and validated to measure voriconazole trough levels in human plasma. The plasma samples were mixed with fluconazole as an Internal Standard and directed to protein precipitation and drug extraction. An aliquot of 1 μl was injected into the chromatographic system and separated by the Acquity BEH C18 column at a flow rate of 0.30 ml/min in a gradient mobile phase consisting of acetonitrile, Ultrapure water (UPW), methanol and formic acid. Voriconazole was detected by a Triple Quadrupole Detector (TQD) operating on Multiple Reaction Monitoring (MRM) and a positive ion mode Electrospray ionization (ESI) Q1 mass: 350.1 m/z, Q3 mass: 281.1 m/z. Method linearity of the calibration curve (0.10 - 8.00 μg/ml) indicated a correlation coefficient r ≥ 0.99. The intra and inter-assay accuracy was within 85% - 115% and the intra and inter-assay precision was ≤5.76%. Voriconazole recovery percentage was between 97.69 - 119.62%. The method was successively applied in routine voriconazole TDM.